Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema.
Luigi CaponePietro AiraghiPasquale AragonaNiccolò CastellinoMaria Vittoria CicinelliFrancesco CiucciMichele CoppolaCristiano De GaetanoRosangela LattanzioLorusso MassimoMartina MaceroniMaria Elena MalvasiLuisa MarcoMichele MarraffaGaia MartiniRodolfo MastropasquaAngelo Maria MinnellaEleni NikolopulouElina OrtisiPacella ElenaVincenzo PapaClaudio PennesiMichele ReibaldiStanislao RizzoLisa TotoLuigi TrombettaFrancesco BandelloPublished in: European journal of ophthalmology (2024)
FAc implant provides a substantial long-term functional and anatomical benefit when used as second-line treatment in eyes with DME. IOP rise can be adequately managed with topical agents although some eyes may require IOP-lowering surgery.